Antibodies to watch in 2026, S Crescioli, H Kaplon, A Chenoweth, YS Hsu, K Pinto, V Kapoor, ...,MAbs 18 (1), 2614669
Rewiring immunity: Midkine’s emerging role in cancer immune escape and drug resistance, M Saikia, S Prem, V Kapoor, Iscience 29 (5)
Radiation-mediated complement cascade activation within the lung tumor microenvironment diminishes the efficacy of radiation therapy, H Shah, M Saikia, X Wu, JP Atkinson, AK Singh, V Kapoor, Cancer Research 86 (7_Supplement), 7377-7377
Complement system in cancer: friend or foe of immunotherapy, HK Shah, S Prem, X Wu, MK Liszewski, JP Atkinson, AK Singh, V Kapoor, Journal for Immunotherapy of Cancer 14 (3), e013290
Antibodies to watch in 2025, S Crescioli, H Kaplon, L Wang, J Visweswaraiah, V Kapoor, JM Reichert, MAbs 17 (1), 2443538
The TROP2 targeting antibody-drug conjugate IMMU-132 enhances the efficacy of radiation therapy for lung cancer, V Kapoor, H Shah, S Prem, R Bose, A Singh
Blocking the functional domain of cancer cell surface TIP1 upregulates Midkine via the β-catenin/Wnt signaling pathway, M Saikia, HK Shah, DE Hallahan, AK Singh, V Kapoor, Cancer gene therapy 32 (7), 785-792
Radiation-mediated complement alternative pathway activation within the lung tumor microenvironment diminishes the efficacy of therapy, H Shah, M Saikia, X Wu, J Atkinson, D Hallahan, A Singh, V Kapoor, EUROPEAN JOURNAL OF IMMUNOLOGY 54, 234-234
Application of CRISPR in Cancer Research and Treatment, AK Singh, V Kapoor, RK Gupta, Molecular Biomarkers for Cancer Diagnosis and Therapy, 101-110
Development of a [89Zr]Zr-labeled Human Antibody using a Novel Phage-displayed Human scFv Library, AK Singh, CD Lewis, CAWV Boas, P Diebolder, PN Jethva, A Rhee, ...,Clinical Cancer Research 30 (7), 1293-1306
Blocking the functional domain of TIP1 by antibodies sensitizes cancer to radiation therapy, AK Singh, DYA Dadey, MJ Rau, J Fitzpatrick, HK Shah, M Saikia, ..., Biomedicine & Pharmacotherapy 166, 115341
Role of midkine in cancer drug resistance: regulators of its expression and its molecular targeting, M Saikia, N Cheung, AK Singh, V Kapoor, International journal of molecular sciences 24 (10), 8739
Preclinical development of a 89Zr-labeled human antibody as a novel immuno-PET agent for noninvasive cancer detection and monitoring response to treatment, AK Singh, CD Lewis, CAWV Boas, P Diebolder, PN Jethva, A Rhee, ..., Cancer Research 83 (7_Supplement), 5035-5035
Blocking the functional domain of TIP1 upregulates midkine via the β-catenin/Wnt signaling pathway, M Saikia, AK Singh, N Cheung, DE Hallahan, V Kapoor, Cancer Research 83 (7_Supplement), 2566-2566
Anti-grp78 antibodies and method of use thereof, D Hallahan, AK Singh, V Kapoor, US Patent App. 17/627,502
A human antibody against TIP1 targets lung cancer in vitro and patient-derived xenografts in vivo., A Singh, C Lewis, CWV Boas, P Jethva, B Rogers, D Hallahan, V Kapoor, Journal of Nuclear Medicine 63 (supplement 2), 4061-4061
Antibodies to TIP1 and methods of use thereof, D Hallahan, V Kapoor, H Yan, US Patent 11,352,436
In vitro and in vivo evaluation of a 89Zr-labeled anti-TIP1 antibody, CWV Boas, C Lewis, A Singh, D Hallahan, V Kapoor, B Rogers, Nuclear Medicine and Biology 108, S37-S38
Long-acting recombinant human interleukin-7, NT-I7, increases cytotoxic CD8 T cells and enhances survival in mouse glioma models, JL Campian, S Ghosh, V Kapoor, R Yan, S Thotala, A Jash, T Hu, ..., Clinical Cancer Research 28 (6), 1229-1239
Exploiting radiation induction of antigens in cancer: targeted drug delivery, V Kapoor, AK Singh, CD Lewis, S Deore, DE Hallahan, International journal of molecular sciences 23 (6), 3041